Hypothalamic gonadotropin-releasing hormone (GnRH) plays a critical role in reproductive physiology by regulating folliclestimulating hormone (FSH) and luteinizing hormone (LH) gene expression in the pituitary. Analysis of gonadotrope deep-sequencing data identified a global regulation of pre-mRNA splicing by GnRH. Homer1, a gene encoding a postsynaptic density scaffolding protein, was selected for further study. Homer1 expresses a short splice form, Homer1a, and more-abundant long transcripts Homer1b/c. GnRH induced a modest increase in Homer1b/c expression and a dramatic increase in the Homer1a splice form. G protein knockdown studies suggested that the Homer1 induction, but not the regulated splicing, was G␣q/11 dependent. Phosphorylation of the splicing regulator SRp20 was found to be induced by GnRH. SRp20 depletion attenuated the GnRH-induced increase in the Homer1a-to-Homer1b/c ratio and modulated the effects of GnRH on FSH and LH expression. Homer1 gene knockdown resulted in increased GnRH-induced FSH and LH transcript levels. Furthermore, splice-form-specific reduction of Homer1b/c increased both FSH and LH mRNA induction, whereas reduction of Homer1a had the opposite effect on FSH induction. These results indicate that the regulation of Homer1 splicing by GnRH contributes to gonadotropin gene control.
Gonadotropin-releasing hormone (GnRH) plays a central role in the control of normal reproductive function by regulating the synthesis and release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) by pituitary gonadotropes. These two hormones are heterodimeric proteins composed of a common ␣ subunit and a specific  subunit (1). The control of FSH and LH gene expression by GnRH is critical during the menstrual cycle, including ovulation, and through the various stages of reproductive life (2). Impairment of the gonadotrope response to GnRH results in reproductive disorders such as polycystic ovary syndrome (3) and provides the basis for treatment of gonadal hormone-sensitive cancers (4, 5). Therefore, understanding the molecular mechanisms involved in the response of gonadotropins to GnRH may help discover new therapeutic targets for reproductive disorders and hormone-dependent malignancies.The development of the immortalized gonadotrope cell lines ␣T3-1 and LT2 has facilitated the characterization of the mechanisms regulating gonadotropin subunit gene transcription (6-9). A member of the G-protein-coupled receptor family, the GnRH receptor (GnRHR) is coupled to both G␣ q/11 and G␣ s , which activate protein kinase C/mitogen-activated protein kinase (PKC/ MAPK)-and 3=-5=-cyclic AMP (cAMP)/protein kinase A-dependent pathways, respectively (for a review, see reference 10). GnRH induction of LH involves PKC/MAPK signaling and the synergistic interaction of early growth response 1, steroidogenic factor 1, and paired-like homeodomain transcription factor 1 (11). Additionally, cAMP may augment LH gene transcription (12, 13). GnRH induction of FSH is mediated by the...